Conditions: Non-small Cell Lung Cancer Mesothelioma Lung Neoplasms
Allocation: NON_RANDOMIZED | Intervention model: SINGLE_GROUP
Enrollment: 31
Healthy volunteers: no

Brief summary:
This study will test the effects of pemetrexed on mesothelioma and non-small cell lung cancer patients with fluid around their lungs or abdomen.

Detailed description:

Arms:
arm 1: Pemetrexed 500 mg/m\^2 intravenous (IV) every 21 days for 6 cycles

Interventions: intervention 1: pemetrexed
Intervention descriptions: intervention 1: 500 milligrams per meter squared (mg/m\^2) IV every 21 days for 6 cycles

Protocol document: